Gon­or­rhea an­tibi­otic re­sis­tance threat looms for gay/bi­sex­ual men

GA Voice - - Newsbriefs -

When other celebri­ties re­main quiet out of fear of alien­at­ing their fan­base or im­pact- ing their net worth in the wake of anti-gay vi­o­lence and re­peated shoot­ings of un­armed black men by police, At­lanta Dream point guard and les­bian Layshia Claren­don is as out­spo­ken as ever.

Now in her first sea­son with the At­lanta Dream after pre­vi­ously play­ing three sea­sons for the In­di­ana Fever, Claren­don de­scribes her­self as “bira­cial, black, gay, fe­male, gen­derqueer and Chris­tian.” She is also quickly adding ac­tivist to her list of iden­ti­fiers. One scroll through her Twit­ter or In­sta­gram feed and you’re likely to read her thoughts on fem­i­nism, white supremacy and the re­cent shoot­ing of Al­ton Ster­ling, a black man whose fi­nal mo­ments were cap­tured on video as he was shot mul­ti­ple times by police out­side a con­ve­nience store in Ba­ton Rouge, Louisiana.

“Woke to the news that yet another black man was mur­dered by the police. Another hash­tag, another day, another in­jus­tice. #Al­tonSter­ling,” she tweeted on July 8. The Cen­ter for Dis­ease Con­trol and Pre­ven­tion re­leased their find­ings on July 14 in the Mor­bid­ity and Mor­tal­ity Weekly Re­port on the grow­ing threat of re­sis­tance to azithromycin, the an­tibi­otic used to treat gon­or­rhea.

“The con­flu­ence of emerg­ing drug re­sis­tance and very lim­ited al­ter­na­tive op­tions for treat­ment cre­ates a per­fect storm for fu­ture gon­or­rhea treat­ment fail­ure in the U.S.,” said Jonathan Mer­min, M.D., direc­tor of the CDC’s Na­tional Cen­ter for HIV/AIDS, Vi­ral Hep­ati­tis, STD, and Tu­ber­cu­lo­sis Pre­ven­tion.

“His­tory shows us that bac­te­ria will find a way to out­last the an­tibi­otics we’re us­ing to treat it. We are run­ning just one step ahead in or­der to pre­serve the re­main­ing treat­ment op­tion for as long as pos­si­ble.”

The com­bi­na­tion ther­apy cur­rently rec­om­mended by CDC still works. To date, no treat­ment fail­ures have been re­ported in the United States.

“It is un­clear how long the com­bi­na­tion ther­apy of azithromycin and cef­tri­ax­one will be ef­fec­tive if the in­creases in re­sis­tance per­sist,” said Gail Bolan, M.D, direc­tor of CDC’s Di­vi­sion of STD Pre­ven­tion. “We need to push for­ward on mul­ti­ple fronts to en­sure we can con­tinue of­fer­ing suc­cess­ful treat­ment to those who need it.”

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.